Table 3. Changes in Lipids from Baseline.

Parameters	Drugs	Change (baseline vs. end of treatment)		p value among drugs†
		Mean (SD)	p value*
Total cholesterol, mg/dL	Atorvastatin	-74.2 (31.8)	<0.001	0.38
	Rosuvastatin	-70.9 (31.9)	<0.001
	Pitavastatin	-71 (49.5)	<0.001
LDL-C, mg/dL	Atorvastatin	-65.7 (21.5)	<0.001	0.58
	Rosuvastatin	-64.6 (28.2)	<0.001
	Pitavastatin	-62.6 (30.5)	<0.001
HDL-C, mg/dL	Atorvastatin	0.65 (4.1)	0.28	0.86
	Rosuvastatin	0.38 (8.0)	0.75
	Pitavastatin	1.1 (3.1)	0.04
Triglycerides, mg/dL	Atorvastatin	-32.8 (71.4)	0.001	0.92
	Rosuvastatin	-27.7 (64.4)	0.001
	Pitavastatin	-33.1 (73.8)	0.001

LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol.

^*Paired Student’s t test; ^†ANOVA test. For explanations see previous tables.